Advances in Data-Driven Responses to Preventing Spread of Antibiotic Resistance Across Health-Care Settings

2019 ◽  
Vol 41 (1) ◽  
pp. 6-12 ◽  
Author(s):  
Scott K Fridkin

Abstract Among the most urgent and serious threats to public health are 7 antibiotic-resistant bacterial infections predominately acquired during health-care delivery. There is an emerging field of health-care epidemiology that is focused on preventing health care–associated infections with antibiotic-resistant bacteria and incorporates data from patient transfers or patient movements within and between facilities. This analytic field is being used to help public health professionals identify best opportunities for prevention. Different analytic approaches that draw on uses of big data are being explored to help target the use of limited public health resources, leverage expertise, and enact effective policy to maximize an impact on population-level health. Here, the following recent advances in data-driven responses to preventing spread of antibiotic resistance across health-care settings are summarized: leveraging big data for machine learning, integration or advances in tracking patient movement, and highlighting the value of coordinating response across institutions within a region.

Antibiotics ◽  
2020 ◽  
Vol 9 (10) ◽  
pp. 688
Author(s):  
Shashi B. Kumar ◽  
Shanvanth R. Arnipalli ◽  
Ouliana Ziouzenkova

Antibiotics have been used as essential therapeutics for nearly 100 years and, increasingly, as a preventive agent in the agricultural and animal industry. Continuous use and misuse of antibiotics have provoked the development of antibiotic resistant bacteria that progressively increased mortality from multidrug-resistant bacterial infections, thereby posing a tremendous threat to public health. The goal of our review is to advance the understanding of mechanisms of dissemination and the development of antibiotic resistance genes in the context of nutrition and related clinical, agricultural, veterinary, and environmental settings. We conclude with an overview of alternative strategies, including probiotics, essential oils, vaccines, and antibodies, as primary or adjunct preventive antimicrobial measures or therapies against multidrug-resistant bacterial infections. The solution for antibiotic resistance will require comprehensive and incessant efforts of policymakers in agriculture along with the development of alternative therapeutics by experts in diverse fields of microbiology, biochemistry, clinical research, genetic, and computational engineering.


2019 ◽  
Vol 20 (6) ◽  
pp. 1255 ◽  
Author(s):  
Ana Monserrat-Martinez ◽  
Yann Gambin ◽  
Emma Sierecki

Since their discovery in the early 20th century, antibiotics have been used as the primary weapon against bacterial infections. Due to their prophylactic effect, they are also used as part of the cocktail of drugs given to treat complex diseases such as cancer or during surgery, in order to prevent infection. This has resulted in a decrease of mortality from infectious diseases and an increase in life expectancy in the last 100 years. However, as a consequence of administering antibiotics broadly to the population and sometimes misusing them, antibiotic-resistant bacteria have appeared. The emergence of resistant strains is a global health threat to humanity. Highly-resistant bacteria like Staphylococcus aureus (methicillin-resistant) or Enterococcus faecium (vancomycin-resistant) have led to complications in intensive care units, increasing medical costs and putting patient lives at risk. The appearance of these resistant strains together with the difficulty in finding new antimicrobials has alarmed the scientific community. Most of the strategies currently employed to develop new antibiotics point towards novel approaches for drug design based on prodrugs or rational design of new molecules. However, targeting crucial bacterial processes by these means will keep creating evolutionary pressure towards drug resistance. In this review, we discuss antibiotic resistance and new options for antibiotic discovery, focusing in particular on new alternatives aiming to disarm the bacteria or empower the host to avoid disease onset.


mBio ◽  
2016 ◽  
Vol 7 (3) ◽  
Author(s):  
Sean Conlan ◽  
Morgan Park ◽  
Clayton Deming ◽  
Pamela J. Thomas ◽  
Alice C. Young ◽  
...  

ABSTRACT Carbapenem-resistant Klebsiella pneumoniae strains are formidable hospital pathogens that pose a serious threat to patients around the globe due to a rising incidence in health care facilities, high mortality rates associated with infection, and potential to spread antibiotic resistance to other bacterial species, such as Escherichia coli . Over 6 months in 2011, 17 patients at the National Institutes of Health (NIH) Clinical Center became colonized with a highly virulent, transmissible carbapenem-resistant strain of K. pneumoniae . Our real-time genomic sequencing tracked patient-to-patient routes of transmission and informed epidemiologists’ actions to monitor and control this outbreak. Two of these patients remained colonized with carbapenemase-producing organisms for at least 2 to 4 years, providing the opportunity to undertake a focused genomic study of long-term colonization with antibiotic-resistant bacteria. Whole-genome sequencing studies shed light on the underlying complex microbial colonization, including mixed or evolving bacterial populations and gain or loss of plasmids. Isolates from NIH patient 15 showed complex plasmid rearrangements, leaving the chromosome and the bla KPC -carrying plasmid intact but rearranging the two other plasmids of this outbreak strain. NIH patient 16 has shown continuous colonization with bla KPC -positive organisms across multiple time points spanning 2011 to 2015. Genomic studies defined a complex pattern of succession and plasmid transmission across two different K. pneumoniae sequence types and an E. coli isolate. These findings demonstrate the utility of genomic methods for understanding strain succession, genome plasticity, and long-term carriage of antibiotic-resistant organisms. IMPORTANCE In 2011, the NIH Clinical Center had a nosocomial outbreak involving 19 patients who became colonized or infected with bla KPC -positive Klebsiella pneumoniae . Patients who have intestinal colonization with bla KPC -positive K. pneumoniae are at risk for developing infections that are difficult or nearly impossible to treat with existing antibiotic options. Two of those patients remained colonized with bla KPC -positive Klebsiella pneumoniae for over a year, leading to the initiation of a detailed genomic analysis exploring mixed colonization, plasmid recombination, and plasmid diversification. Whole-genome sequence analysis identified a variety of changes, both subtle and large, in the bla KPC -positive organisms. Long-term colonization of patients with bla KPC -positive Klebsiella pneumoniae creates new opportunities for horizontal gene transfer of plasmids encoding antibiotic resistance genes and poses complications for the delivery of health care.


Water ◽  
2021 ◽  
Vol 13 (23) ◽  
pp. 3342
Author(s):  
Jörg Londong ◽  
Marcus Barth ◽  
Heinrich Söbke

Antimicrobial resistance (AMR) is identified by the World Health Organization (WHO) as one of the top ten threats to public health worldwide. In addition to public health, AMR also poses a major threat to food security and economic development. Current sanitation systems contribute to the emergence and spread of AMR and lack effective AMR mitigation measures. This study assesses source separation of blackwater as a mitigation measure against AMR. A source-separation-modified combined sanitation system with separate collection of blackwater and graywater is conceptually described. Measures taken at the source, such as the separate collection and discharge of material flows, were not considered so far on a load balance basis, i.e., they have not yet been evaluated for their effectiveness. The sanitation system described is compared with a combined system and a separate system regarding AMR emissions by means of simulation. AMR is represented in the simulation model by one proxy parameter each for antibiotics (sulfamethoxazole), antibiotic-resistant bacteria (extended-spectrum beta-lactamase E. Coli), and antibiotic resistance genes (blaTEM). The simulation results suggest that the source-separation-based sanitation system reduces emissions of antibiotic-resistant bacteria and antibiotic resistance genes into the aquatic environment by more than six logarithm steps compared to combined systems. Sulfamethoxazole emissions can be reduced by 75.5% by keeping blackwater separate from graywater and treating it sufficiently. In summary, sanitation systems incorporating source separation are, to date, among the most effective means of preventing the emission of AMR into the aquatic environment.


2021 ◽  
Author(s):  
Xiaomei Dai ◽  
Lele Yang ◽  
Qingqing Xu ◽  
Jifang Ma ◽  
Qiang Zhang ◽  
...  

Bacterial infection is one of the most significant public health challenges due to the limited choices of antibiotics which can overcome antibiotic-resistant bacteria. The promising nonantibiotic therapeutic alternatives for antibiotic-resistant...


2021 ◽  
Author(s):  
Chirag Choudhary ◽  

The idea of using a virus to kill bacteria may seem counterintuitive, but it may be the future of treating bacterial infections. Before the COVID-19 pandemic, one of the most frightening biological agents were so-called “superbugs” – antibiotic resistant bacteria – which could not be treated with conventional therapeutics. When antibiotics were first developed, they were hailed as a panacea. A panacea they were not.


2021 ◽  
Author(s):  
Lihui Yuwen ◽  
Qiu Qiu ◽  
Wei-Jun Xiu ◽  
Kaili Yang ◽  
Yuqing Li ◽  
...  

Infectious diseases associated with antibiotic-resistant bacteria are ever-growing threats to public health. Effective treatment and detection methods of bacterial infections are in urgent demand. Herein, novel phototheranostic nanoagents (MoS2@HA-Ce6 nanosheets,...


Author(s):  
Ajid K. Mule ◽  
Suraj Malpani ◽  
Shradha T. Nemane ◽  
Sushil S. Kore ◽  
Ayaj S. Pathan

Antibiotics are the ‘wonder drugs’ to combat microbes. For decades, various types of antibiotics have not only been used for therapeutic purposes but practiced prophylactically across other industries such as agriculture and animal husbandry. Antibiotic-resistant infections correlate with the level of antibiotic consumption. Non-judicial use of antibiotics is one of the reason for making the microbes resistant. The antibiotic therapy store for emerging hard-to-treat multidrug-resistant bacterial infections is limited, resulting in high morbidity and mortality report. As per the World Health Organization “First worldwide Report on Antibiotic Resistance”, and the U.S. Centers for Disease Control & Prevention (CDC&P) and the spread of “superbugs” - bacteria that have changed in ways that provided antibiotics non effective against them - is a severe and growing threat around the world. Once common treatments for not only everyday intestinal and urinary tract infections but also pneumonia as well as infections in newborn and diseases like gonorrhea are no longer working in people. Thus, in 2013, two million people in the U.S. were affected by antibiotic-resistant bacteria, and 23,000 of them die each year as a result. Keywords: Wonder drugs, antibiotic resistance, CDC&P, Superbugs etc.


2019 ◽  
Vol 63 (8) ◽  
Author(s):  
Monika Dolejska ◽  
Ivan Literak

ABSTRACT Wild animals foraging in the human-influenced environment are colonized by bacteria with clinically important antibiotic resistance. The occurrence of such bacteria in wildlife is influenced by various biological, ecological, and geographical factors which have not yet been fully understood. More research focusing on the human-animal-environmental interface and using novel approaches is required to understand the role of wild animals in the transmission of antibiotic resistance and to assess potential risks for the public health.


Sign in / Sign up

Export Citation Format

Share Document